Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Opinion|Videos|June 13, 2024

Non-Pharmacologic Interventions for Pediatric Patients with Narcolepsy

Author(s)Karl Doghramji, MD, Chelsie Monroe, MSN, APN, PMHNP-BC

Experts on narcolepsy offer perspectives on non-pharmacologic interventions for pediatric patients with narcolepsy, including lifestyle changes.

Episodes in this series

Video 1 - "Definition of Narcolepsy and Unmet Needs"

EP. 1 Definition of Narcolepsy and Unmet Needs

Video 2 - "Pathophysiology of Narcolepsy and the Role of Orexins"

EP. 2 Pathophysiology of Narcolepsy and the Role of Orexins

Video 2 - "Diagnostic Practices for Narcolepsy"

EP. 3 Diagnostic Practices for Narcolepsy

Video 2 - "Narcolepsy Evaluation, Management, and Treatment Considerations"

EP. 4 Narcolepsy Evaluation, Management, and Treatment Considerations

Video 5 - "Clinical Treatment Strategies for a Patient Suffering from EDS and Hypnagogic Hallucinations"

EP. 5 Clinical Treatment Strategies for a Patient Suffering from EDS and Hypnagogic Hallucinations

Video 6 - "Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks"

EP. 6 Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks

Video 7 - "Complex Case of a 23-Year-Old Male College Student Suffering From Narcolepsy Symptoms"

EP. 7 Complex Case of a 23-Year-Old Male College Student Suffering From Narcolepsy Symptoms

Video 8 - "Treatment Augmentation in a Patient with Narcolepsy and ADHD"

EP. 8 Treatment Augmentation in a Patient with Narcolepsy and ADHD

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA

EP. 9 Considerations for the Management of Pediatric Patients with Narcolepsy

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA

EP. 10 Non-Pharmacologic Interventions for Pediatric Patients with Narcolepsy

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA

EP. 11 Clinical Pearls for the Management of Patients Suffering from Narcolepsy

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related to this article

narcolepsy

September 9th, 2026

New Phase 3 Data on Oveporexton for Narcolepsy Type 1

Phase 3 NEJM data show oveporexton improves wakefulness, reduces cataplexy, and boosts quality of life in narcolepsy type 1, with manageable adverse effects.

Trending on Psychiatric Times

FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval

Vol 43, Issue 9 - Interactive

Debunking the Top 10 Misleading Claims About Antidepressants

What Low Doses of VRAYLAR® (Cariprazine) May Mean for Clinical Practice

Embodied Technologies for Mental Health: Leveraging Synthetic Emotions for Dissociation and Anhedonia